2025
Barriers and facilitators to injectable opioid agonist treatment engagement within a structural vulnerability context: a qualitative study of patient experiences in Vancouver, Canada
Mayer S, Fairbairn N, Fowler A, Boyd J, Kerr T, McNeil R. Barriers and facilitators to injectable opioid agonist treatment engagement within a structural vulnerability context: a qualitative study of patient experiences in Vancouver, Canada. Harm Reduction Journal 2025, 22: 116. PMID: 40615907, PMCID: PMC12228173, DOI: 10.1186/s12954-025-01262-4.Peer-Reviewed Original ResearchConceptsSocial servicesStructural vulnerabilityVancouver’s Downtown Eastside neighbourhoodRelated careInjectable opioid agonist treatmentUse-related risksHousing instabilityVulnerability lensObservational fieldworkVulnerability contextFieldwork observationsOpioid agonist treatment engagementQualitative interviewsPeople's engagementQualitative studies of patients' experiencesExperiences of barriersStudies of patients' experiencesHealthcare provider supervisionMobility challengesFollow-up interviewsImprove accessSocial supportQualitative studyFieldworkBarriers to treatmentMedicare Parity and Outpatient Mental Health Service Use and Costs Among Beneficiaries With Depression
Tetlow S, Phillips V, Hockenberry J. Medicare Parity and Outpatient Mental Health Service Use and Costs Among Beneficiaries With Depression. JAMA Network Open 2025, 8: e258491. PMID: 40314953, PMCID: PMC12048850, DOI: 10.1001/jamanetworkopen.2025.8491.Peer-Reviewed Original ResearchConceptsMental health service useOutpatient mental health service useHealth service useOut-of-pocket expenditureMental health servicesOutpatient mental health servicesService useMedicare beneficiariesHealth servicesDepression screeningUS Preventive Services Task Force recommendationsAccessibility of mental health servicesMedical Expenditure Panel Survey Household ComponentInterrupted time series designOutpatient mental healthMental health careCost-sharingMental health conditionsEconomic evaluationProportion of beneficiariesTask Force recommendationsBarriers to treatmentNationally Representative SampleTime series designOlder with depressionBarriers to and impacts of hepatitis C treatment among people who inject drugs in Kenya: A qualitative study
Manley H, Riback L, Nyakowa M, Akiyama M, Cherutich P, Lizcano J, Kurth A, Muller A. Barriers to and impacts of hepatitis C treatment among people who inject drugs in Kenya: A qualitative study. PLOS Global Public Health 2025, 5: e0003284. PMID: 39821143, PMCID: PMC11737709, DOI: 10.1371/journal.pgph.0003284.Peer-Reviewed Original ResearchDrop-in-centersRhodes' risk environment framework,HCV-related stigmaReduce barriers to treatmentSystem-level changesBarriers to treatmentMiddle-income countriesTreatment programsBarriers to HCV treatmentRisk environment frameworkExperiences of PWIDHCV treatment programSemi-structured interviewsBarriers patientsHCV treatmentLMIC settingsTranscribed interviewsThematic analysisCase managementQualitative studyPositive treatment outcomesTreatment accessRisk behaviorsImplementing treatment programsPWID
2024
Therapy Mode Preference Scale: Preliminary Validation Methodological Design
Cerrito B, Xiao J, Fialk A, Buono F. Therapy Mode Preference Scale: Preliminary Validation Methodological Design. JMIR Formative Research 2024, 8: e65477. PMID: 39612373, PMCID: PMC11623782, DOI: 10.2196/65477.Peer-Reviewed Original ResearchConceptsZoom Exhaustion and Fatigue scaleIn-person careHierarchical linear regressionHealth careIn-personExploratory factor analysisInternal consistencyMental health treatment programsSatisfactory levels of internal consistencyFactor analysisLevels of internal consistencyIn-person therapyKaiser-Meyer-Olkin measure of sampling adequacyClient Satisfaction QuestionnaireKaiser-Meyer-Olkin measureBartlett's test of sphericityHealth care demandBarriers to treatmentMeasure of sampling adequacyTest of sphericityIncremental validityFactor structureFatigue ScaleLinear regressionCare demandsStrategic Treatment and Assessment for Youth (STAY): A Theoretically-Driven, Culturally-Tailored MBC Approach
Arora P, Awad M, Parr K, Connors E. Strategic Treatment and Assessment for Youth (STAY): A Theoretically-Driven, Culturally-Tailored MBC Approach. Administration And Policy In Mental Health And Mental Health Services Research 2024, 52: 261-276. PMID: 39541064, PMCID: PMC11703679, DOI: 10.1007/s10488-024-01419-6.Peer-Reviewed Original ResearchMeasurement-based careREM youthTreatment retentionDepressive symptomsTheoretically-drivenImprove treatment retentionAlliance measuresBarriers to treatmentPremature dropoutSuicide riskSuicidal thoughtsTreatment engagementREM populationsFeedback processesClient outcomesTreatment expectationsREMWhite peersSuicideYouthCultural competency trainingCompetency trainingSymptomsTreatment assessmentDepressionExploring the Experience of Pain and Pain Management for Pregnant and Postpartum Veterans with Chronic Musculoskeletal Pain
Kroll-Desrosiers A, Wallace K, Higgins D, Martino S, Marteeny V, Walker L, Mattocks K. Exploring the Experience of Pain and Pain Management for Pregnant and Postpartum Veterans with Chronic Musculoskeletal Pain. Women's Health Issues 2024, 34: 628-635. PMID: 39242321, DOI: 10.1016/j.whi.2024.07.004.Peer-Reviewed Original ResearchVeterans Health AdministrationExperience of painPain carePain managementPerinatal periodVeterans Health Administration providersImprove pain careHigh-quality careChronic musculoskeletal painImprove pain managementBarriers to treatmentPostpartum veteransPregnant veteransMusculoskeletal conditionsMusculoskeletal painBack painFramework approachHealth coverageHealth AdministrationPain diagnosisVeterans' experiencesIdentified veteransQualitative studyUnique needsCareUncertainty in tuberculosis clinical decision-making: An umbrella review with systematic methods and thematic analysis
Basile F, Sweeney S, Singh M, Bijker E, Cohen T, Menzies N, Vassall A, Indravudh P. Uncertainty in tuberculosis clinical decision-making: An umbrella review with systematic methods and thematic analysis. PLOS Global Public Health 2024, 4: e0003429. PMID: 39042611, PMCID: PMC11265660, DOI: 10.1371/journal.pgph.0003429.Peer-Reviewed Original ResearchUmbrella reviewClinical decision-makingHealthcare system levelQualitative evidence synthesisBarriers to treatmentScarcity of healthcare resourcesTuberculosis knowledgeClinicians' attitudesCommon barriersResource-limited settingsHealth careHealthcare settingsClinical encountersEvidence synthesisInfluence clinical decisionsThematic analysisHealthcare resourcesDiagnostic test characteristicsStudy designSystematic reviewMeta-analysesNegative test resultsMulti-level modelProvidersDecision-making
2023
Life-Saving Treatments for Spinal Muscular Atrophy: Global Access and Availability.
Armengol V, Darras B, Abulaban A, Alshehri A, Barisic N, Ben-Omran T, Bernert G, Castiglioni C, Chien Y, Farrar M, Kandawasvika G, Khadilkar S, Mah J, Marini-Bettolo C, Osredkar D, Pfeffer G, Piazzon F, Pitarch Castellano I, Quijano-Roy S, Saito K, Shin J, Vázquez-Costa J, Walter M, Wanigasinghe J, Xiong H, Griggs R, Roy B. Life-Saving Treatments for Spinal Muscular Atrophy: Global Access and Availability. Neurology Clinical Practice 2023, 14: e200224. PMID: 38107546, PMCID: PMC10723640, DOI: 10.1212/cpj.0000000000200224.Peer-Reviewed Original ResearchSurveyed health care providersProvider survey responsesHealth care providersSpinal muscular atrophyEconomic burdenNewborn screeningBarriers to treatmentMitigate such inequalitiesCare providersClinical careQualitative studyTreated patientsOutcome measuresMotor strengthGenetic testingSpinal muscular atrophy type 1Muscular atrophyProvidersSurvey responsesTreatment of spinal muscular atrophyLife-saving treatmentMuscle weaknessProgressive muscle weaknessNormal lifeTreatment costsAsylee perspectives on psychotherapies for posttraumatic stress
Cassidy G, McQuaid J, Heatherington L, Su C. Asylee perspectives on psychotherapies for posttraumatic stress. Journal Of Traumatic Stress 2023, 36: 373-384. PMID: 36882382, DOI: 10.1002/jts.22917.Peer-Reviewed Original ResearchConceptsPosttraumatic stress disorderNarrative Exposure TherapyInterpersonal therapyCA-CBTSymptoms of posttraumatic stress disorderPTSD interventionsTreating trauma-related symptomsExposure to traumatic experiencesExposure-based treatmentsEye movement desensitizationCognitive behavioral therapyTrauma-related symptomsPerceived barriers to treatmentPrevalence of mental health concernsMedium effect sizeMental health concernsBarriers to treatmentMovement desensitizationExposure therapyPosttraumatic distressBehavioral therapyStress disorderPosttraumatic stressTreatment engagementMeta-analyses of randomized controlled trials
2022
Postdeployment Treatment Gap: Symptoms and Treatment Utilization Among Returning National Guard Soldiers
Goldberg S, Flynn A, Abbas M, Schultz M, Hiserodt M, Thomas K, Kallio K, Wyman M. Postdeployment Treatment Gap: Symptoms and Treatment Utilization Among Returning National Guard Soldiers. The Counseling Psychologist 2022, 50: 506-535. PMID: 35936651, PMCID: PMC9354595, DOI: 10.1177/00110000221074019.Peer-Reviewed Original ResearchPosttraumatic stress disorderMental health treatment utilizationAlcohol use disorderMental health treatmentNational Guard service membersPsychiatric symptomsTreatment utilizationHealth treatmentPost-deployment periodRates of psychiatric symptomsEmotion regulation strategiesService membersSeverity of depressionNational Guard soldiersPost-deploymentSymptoms of depressionClinical cut-offBarriers to treatmentStress disorderSymptom measuresUse disorderRegulation strategiesFollow-upDepressionSymptoms
2019
Factors Associated With Use of Sipuleucel-T to Treat Patients With Advanced Prostate Cancer
Caram M, Ross R, Lin P, Mukherjee B. Factors Associated With Use of Sipuleucel-T to Treat Patients With Advanced Prostate Cancer. JAMA Network Open 2019, 2: e192589. PMID: 31002323, PMCID: PMC6481456, DOI: 10.1001/jamanetworkopen.2019.2589.Peer-Reviewed Original ResearchConceptsMinimally symptomatic metastatic castration-resistant prostate cancerSipuleucel-TProstate cancerSymptomatic metastatic castration-resistant prostate cancerDatabase of commercially insured patientsMetastatic castration-resistant prostate cancerCastration-resistant prostate cancerAge of patientsRetrospective cohort studyFactors associated with useAssociated with patientsCommercially insured patientsPatterns of treatmentConcurrent therapyTreated patientsCohort studyMultivariate analysisCancer therapyTherapyPatientsPhysician factorsCancerBarriers to treatmentBinomial logistic regressionLogistic regression
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply